Consolidated Statement Of Profit Or Loss

ONO PHARMACEUTICAL CO., LTD. - Filing #7242262

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
486,871,000,000 JPY
502,672,000,000 JPY
Cost of sales
147,950,000,000 JPY
127,126,000,000 JPY
Gross profit
338,921,000,000 JPY
375,547,000,000 JPY
Selling, general and administrative expenses
125,671,000,000 JPY
100,270,000,000 JPY
Other income
1,110,000,000 JPY
1,176,000,000 JPY
Other expenses
4,746,000,000 JPY
4,343,000,000 JPY
Operating profit (loss)
59,747,000,000 JPY
159,935,000,000 JPY
Finance income
4,774,000,000 JPY
4,027,000,000 JPY
Finance costs
5,318,000,000 JPY
229,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
125,000,000 JPY
1,000,000 JPY
Profit (loss) before tax
59,328,000,000 JPY
163,734,000,000 JPY
Income tax expense
9,163,000,000 JPY
35,694,000,000 JPY
Profit (loss)
50,047,000,000 JPY
50,047,000,000 JPY
119,000,000 JPY
50,166,000,000 JPY
127,977,000,000 JPY
127,977,000,000 JPY
128,040,000,000 JPY
62,000,000 JPY
Profit (loss) attributable to
Owners of parent
50,047,000,000 JPY
127,977,000,000 JPY
Non-controlling interests
119,000,000 JPY
62,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
106.55
266.61
Diluted earnings (loss) per share
106.41
266.57

Talk to a Data Expert

Have a question? We'll get back to you promptly.